). Control and . Ccfd, Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men, MMWR Morb Mortal Wkly Rep, vol.30, issue.25, pp.305-308, 1981.

F. Barre-sinoussi, J. C. Chermann, F. Rey, M. T. Nugeyre, S. Chamaret et al., Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS), Science, vol.220, issue.4599, pp.868-871, 1983.

M. Popovic, M. G. Sarngadharan, E. Read, and R. C. Gallo, Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS, Science, vol.224, issue.4648, pp.497-500, 1984.

S. Mboup, M. Essex, P. Kank, I. Ndoye, F. Barin et al.,

, Afr J Sex Transmi Dis, vol.2, issue.2, pp.81-84, 1986.

R. De-leys, B. Vanderborght, M. Vanden-haesevelde, L. Heyndrickx, A. Van-geel et al., Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of westcentral African origin, J Virol, vol.64, issue.3, pp.1207-1216, 1990.

F. Simon, P. Mauclere, P. Roques, I. Loussert-ajaka, M. C. Muller-trutwin et al., Identification of a new human immunodeficiency virus type 1 distinct from group M and group O, Nat Med, vol.4, issue.9, pp.1032-1037, 1998.

J. C. Plantier, M. Leoz, J. E. Dickerson, D. Oliveira, F. Cordonnier et al., A new human immunodeficiency virus derived from gorillas, Nat Med, vol.15, issue.8, pp.871-872, 2009.

J. M. Huraux, J. C. Nicolas, H. Agut, P. Lafeuille, and H. Traité-de-virologie-médicale, , 2003.

P. M. Girard, C. Katlama, G. Pialoux, . Vih, and . Doin, , 2011.

C. A. Janeway, P. Travers, M. Walport, and M. J. Shlomchik, Immunobiology. Garland Science, 2005.

E. Cassan, A. M. Arigon-chifolleau, J. M. Mesnard, A. Gross, and O. Gascuel, Concomitant emergence of the antisense protein gene of HIV-1 and of the pandemic, Proc Natl Acad Sci, vol.113, issue.41, pp.11537-11542, 2016.
URL : https://hal.archives-ouvertes.fr/lirmm-01397005

P. Cappy, A. Moisan, D. Oliveira, F. Plantier, J. C. Negroni et al., HIV-1 sequences in the epidemic suggest an alternative pathway for the generation of the Long Terminal Repeats, Sci Rep, vol.7, issue.1, p.13715, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02171270

A. M. Fulton, P. D. Rathjen, S. M. Kingsman, and A. J. Kingsman, Upstream and downstream transcriptional control signals in the yeast retrotransposon, TY. Nucleic Acids Res, vol.16, issue.12, pp.5439-5458, 1988.

S. Neil and P. Bieniasz, Human immunodeficiency virus, restriction factors, and interferon, J Interferon Cytokine Res, vol.29, issue.9, pp.569-580, 2009.

M. H. Malim and M. Emerman, HIV-1 accessory proteins--ensuring viral survival in a hostile environment, Cell Host Microbe, vol.3, issue.6, pp.388-398, 2008.

N. Laguette and M. Benkirane, How SAMHD1 changes our view of viral restriction, Trends Immunol, vol.33, issue.1, pp.26-33, 2012.

F. Kirchhoff, Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses, Cell Host Microbe, vol.8, issue.1, pp.55-67, 2010.

M. D. Daugherty and H. S. Malik, Rules of engagement: molecular insights from host-virus arms races, Annu Rev Genet, vol.46, pp.677-700, 2012.

S. F. Kluge, D. Sauter, and F. Kirchhoff, SnapShot: antiviral restriction factors, Cell, vol.163, issue.3, pp.774-774, 2015.

D. Sauter and F. Kirchhoff, HIV replication: a game of hide and sense, Curr Opin HIV AIDS, vol.11, issue.2, pp.173-181, 2016.

P. J. Mclaren, A. Gawanbacht, N. Pyndiah, C. Krapp, D. Hotter et al., Identification of potential HIV restriction factors by combining evolutionary genomic signatures with functional analyses, Retrovirology, vol.12, p.41, 2015.

O. T. Fackler, Spotlight on HIV-1 Nef: SERINC3 and SERINC5 Identified as Restriction Factors Antagonized by the Pathogenesis Factor, Viruses, vol.7, issue.12, pp.6730-6738, 2015.

M. Stremlau, C. M. Owens, M. J. Perron, M. Kiessling, P. Autissier et al., The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys, Nature, vol.427, issue.6977, pp.848-853, 2004.

K. Strebel, J. Luban, and K. T. Jeang, Human cellular restriction factors that target HIV-1 replication, BMC Med, vol.7, p.48, 2009.

Y. L. Chiu, V. B. Soros, J. F. Kreisberg, K. Stopak, W. Yonemoto et al., Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells, Nature, vol.435, issue.7038, pp.108-114, 2005.

R. Suspene, P. Sommer, M. Henry, S. Ferris, D. Guetard et al., APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase, Nucleic Acids Res, vol.32, issue.8, pp.2421-2429, 2004.
URL : https://hal.archives-ouvertes.fr/pasteur-00166616

Q. Yu, R. Konig, S. Pillai, K. Chiles, M. Kearney et al., Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome, Nat Struct Mol Biol, vol.11, issue.5, pp.435-442, 2004.

H. Huthoff and G. J. Towers, Restriction of retroviral replication by APOBEC3G/F and TRIM5alpha, Trends Microbiol, vol.16, issue.12, pp.612-619, 2008.

S. Kupzig, V. Korolchuk, R. Rollason, A. Sugden, A. Wilde et al., Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology, Traffic, vol.4, issue.10, pp.694-709, 2003.

D. Sauter, A. Specht, and F. Kirchhoff, Tetherin: holding on and letting go, Cell, vol.141, issue.3, pp.392-398, 2010.

J. L. Douglas, K. Viswanathan, M. N. Mccarroll, J. K. Gustin, K. Fruh et al., Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism, J Virol, vol.83, issue.16, pp.7931-7947, 2009.

C. Goffinet, I. Allespach, S. Homann, H. M. Tervo, A. Habermann et al., HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor, Cell Host Microbe, vol.5, issue.3, pp.285-297, 2009.

R. K. Gupta, S. Hue, T. Schaller, E. Verschoor, D. Pillay et al., Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion, PLoS Pathog, vol.5, issue.5, p.1000443, 2009.

B. Mangeat, G. Gers-huber, M. Lehmann, M. Zufferey, J. Luban et al., HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation, PLoS Pathog, vol.5, issue.9, p.1000574, 2009.

Y. Usami, Y. Wu, and H. G. Gottlinger, SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef, Nature, vol.526, issue.7572, pp.218-223, 2015.

C. Goffinet, Cellular Antiviral Factors that Target Particle Infectivity of HIV-1, Curr HIV Res, vol.14, issue.3, pp.211-216, 2016.

Y. Usami and H. Gottlinger, HIV-1 Nef responsiveness is determined by Env variable regions involved in trimer association and correlates with neutralization sensitivity, Cell Rep, vol.5, issue.3, pp.802-812, 2013.

A. Rosa, A. Chande, S. Ziglio, D. Sanctis, V. Bertorelli et al., HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation, Nature, vol.526, issue.7572, pp.212-217, 2015.

B. Descours, A. Cribier, C. Chable-bessia, D. Ayinde, G. Rice et al., SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cells, Retrovirology, vol.9, p.87, 2012.
URL : https://hal.archives-ouvertes.fr/pasteur-00750469

H. Lahouassa, W. Daddacha, H. Hofmann, D. Ayinde, E. C. Logue et al., SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates, Nat Immunol, vol.13, issue.3, pp.223-228, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00675672

K. Hrecka, C. Hao, M. Gierszewska, S. K. Swanson, M. Kesik-brodacka et al., Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein, Nature, vol.474, issue.7353, pp.658-661, 2011.

N. Laguette, B. Sobhian, N. Casartelli, M. Ringeard, C. Chable-bessia et al., SAMHD1 is the dendriticand myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx, Nature, vol.474, issue.7353, pp.654-657, 2011.

A. Brandariz-nunez, J. C. Valle-casuso, T. E. White, N. Laguette, M. Benkirane et al., Role of SAMHD1 nuclear localization in restriction of HIV-1 and SIVmac, Retrovirology, vol.9, p.49, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00722913

C. Goujon, L. Riviere, L. Jarrosson-wuilleme, J. Bernaud, D. Rigal et al., SIVSM/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells, Retrovirology, vol.4, issue.2, 2007.
URL : https://hal.archives-ouvertes.fr/hal-02322992

H. Lahouassa, W. Daddacha, H. Hofmann, D. Ayinde, E. C. Logue et al., SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates, Nat Immunol, vol.13, issue.3, pp.223-228, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00675672

I. A. Tchasovnikarova, R. T. Timms, N. J. Matheson, K. Wals, R. Antrobus et al., Epigenetic silencing by the HUSH complex mediates position-effect variegation in human cells, Science, vol.348, issue.6242, pp.1481-1485, 2015.

N. Liu, C. H. Lee, T. Swigut, E. Grow, B. Gu et al., Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators, Nature, vol.553, issue.7687, pp.228-232, 2018.

G. Chougui, S. Munir-matloob, R. Matkovic, M. M. Martin, M. Morel et al., HIV-2/SIV viral protein X counteracts HUSH repressor complex, Nat Microbiol, vol.3, issue.8, pp.891-897, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01911332

L. Yurkovetskiy, M. H. Guney, K. Kim, S. L. Goh, S. Mccauley et al., Primate immunodeficiency virus proteins Vpx and Vpr counteract transcriptional repression of proviruses by the HUSH complex, Nat Microbiol, vol.3, issue.12, pp.1354-1361, 2018.

L. Etienne, B. H. Hahn, P. M. Sharp, F. A. Matsen, and M. Emerman, Gene loss and adaptation to hominids underlie the ancient origin of HIV-1, Cell Host Microbe, vol.14, issue.1, pp.85-92, 2013.

D. R. Collins, J. Lubow, Z. Lukic, M. Mashiba, and K. L. Collins, Vpr Promotes Macrophage-Dependent HIV-1 Infection of CD4+ T Lymphocytes, PLoS Pathog, vol.11, issue.7, p.1005054, 2015.

M. Mashiba, D. R. Collins, V. H. Terry, and K. L. Collins, Vpr overcomes macrophage-specific restriction of HIV-1 Env expression and virion production, Cell Host Microbe, vol.16, issue.6, pp.722-735, 2014.

N. Laguette, C. Bregnard, P. Hue, J. Basbous, A. Yatim et al., Premature activation of the SLX4 complex by Vpr promotes G2/M arrest and escape from innate immune sensing, Cell, vol.156, issue.1-2, pp.134-145, 2014.
URL : https://hal.archives-ouvertes.fr/hal-00957510

E. A. Cohen, From arrest to escape: HIV-1 Vpr cuts a deal, Cell Host Microbe, vol.15, issue.2, pp.125-127, 2014.

A. Vessière, C. Delaugerre, J. Plantier, and F. Simon, Passages inter-espèces des virus de l'immunodéficience humaine et simienne chez les primates, Revue Francophone des Laboratoires, vol.2010, issue.423, pp.43-53, 2010.

F. Gao, E. Bailes, D. L. Robertson, Y. Chen, C. M. Rodenburg et al., Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes, Nature, vol.397, issue.6718, pp.436-441, 1999.

F. Van-heuverswyn and M. Peeters, The origins of HIV and implications for the global epidemic, Curr Infect Dis Rep, vol.9, issue.4, pp.338-346, 2007.

B. F. Keele, F. Van-heuverswyn, Y. Li, E. Bailes, J. Takehisa et al., Chimpanzee reservoirs of pandemic and nonpandemic HIV-1, Science, vol.313, issue.5786, pp.523-526, 2006.

F. Van-heuverswyn, Y. Li, E. Bailes, C. Neel, B. Lafay et al., Genetic diversity and phylogeographic clustering of SIVcpzPtt in wild chimpanzees in Cameroon, Virology, vol.368, issue.1, pp.155-171, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00412886

M. D'arc, A. Ayouba, A. Esteban, G. H. Learn, V. Boue et al., Origin of the HIV-1 group O epidemic in western lowland gorillas, Proc Natl Acad Sci, vol.112, issue.11, pp.1343-1352, 2015.

S. Locatelli and M. Peeters, Cross-species transmission of simian retroviruses: how and why they could lead to the emergence of new diseases in the human population, AIDS, vol.26, issue.6, pp.659-673, 2012.

T. Mourez, F. Simon, and J. Plantier, Non-M Variants Human Immunodeficiency Virus Type 1, Clinical Microbiology Reviews, vol.26, issue.3, 2013.

P. M. Sharp and B. H. Hahn, Origins of HIV and the AIDS pandemic, Cold Spring Harb Perspect Med, vol.1, issue.1, p.6841, 2011.

M. Peeters, V. Courgnaud, B. Abela, P. Auzel, X. Pourrut et al., Risk to human health from a plethora of simian immunodeficiency viruses in primate bushmeat, Emerg Infect Dis, vol.8, issue.5, pp.451-457, 2002.

A. F. Aghokeng, A. Ayouba, E. Mpoudi-ngole, S. Loul, F. Liegeois et al., Extensive survey on the prevalence and genetic diversity of SIVs in primate bushmeat provides insights into risks for potential new cross-species transmissions, Infect Genet Evol, vol.10, issue.3, pp.386-396, 2010.

E. Simon-lorière, R. Galetto, and M. Negroni, Caractéristiques mécanistiques de la recombinaison chez le virus de l'immunodéficience humaine, 2006.

L. V. Wain, E. Bailes, F. Bibollet-ruche, J. M. Decker, B. F. Keele et al., Adaptation of HIV-1 to its human host, Mol Biol Evol, vol.24, issue.8, pp.1853-1860, 2007.

J. Takehisa, M. H. Kraus, A. Ayouba, E. Bailes, F. Van-heuverswyn et al., Origin and biology of simian immunodeficiency virus in wild-living western gorillas, J Virol, vol.83, issue.4, pp.1635-1648, 2009.

A. Vallari, V. Holzmayer, B. Harris, J. Yamaguchi, C. Ngansop et al., Confirmation of putative HIV-1 group P in Cameroon, J Virol, vol.85, issue.3, pp.1403-1407, 2011.

A. , D. Oliveira, F. Leoz, M. Lemee, V. Robertson et al., HIV-1 group P infection: towards a dead-end infection?, Aids, vol.32, issue.10, pp.1317-1322, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02383299

M. W. Mcnatt, T. Zang, T. Hatziioannou, M. Bartlett, I. B. Fofana et al., Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants, PLoS Pathog, 2009.

N. R. Faria, A. Rambaut, M. A. Suchard, G. Baele, T. Bedford et al., HIV epidemiology. The early spread and epidemic ignition of HIV-1 in human populations, Science, vol.346, issue.6205, pp.56-61, 2014.

M. Leoz, F. Feyertag, A. Kfutwah, P. Mauclere, G. Lachenal et al., The Two-Phase Emergence of Non Pandemic HIV-1 Group O in Cameroon, PLoS Pathog, vol.11, issue.8, p.1005029, 2015.

J. O. Wertheim and M. Worobey, Dating the age of the SIV lineages that gave rise to HIV-1 and HIV-2, PLoS Comput Biol, vol.5, issue.5, p.1000377, 2009.

D. Sauter, S. Hue, S. J. Petit, J. C. Plantier, G. J. Towers et al., HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef, Retrovirology, vol.8, p.103, 2011.

D. D. Ho, A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard et al., Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection, Nature, vol.373, issue.6510, pp.123-126, 1995.

B. D. Preston, B. J. Poiesz, and L. A. Loeb, Fidelity of HIV-1 reverse transcriptase, Science, vol.242, issue.4882, pp.1168-1171, 1988.

W. S. Hu, T. Rhodes, Q. Dang, and V. Pathak, Retroviral recombination: review of genetic analyses, Front Biosci, vol.8, pp.143-155, 2003.

L. M. Mansky and H. M. Temin, Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase, J Virol, vol.69, issue.8, pp.5087-5094, 1995.

A. Rambaut, D. Posada, K. A. Crandall, and E. C. Holmes, The causes and consequences of HIV evolution, Nat Rev Genet, vol.5, issue.1, pp.52-61, 2004.

P. K. Vogt, Genetically stable reassortment of markers during mixed infection with avian tumor viruses, Virology, vol.46, issue.3, pp.947-952, 1971.

W. S. Hu and H. M. Temin, Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination, Proc Natl Acad Sci U S A, vol.87, issue.4, pp.1556-1560, 1990.

F. Clavel, M. D. Hoggan, R. L. Willey, K. Strebel, M. A. Martin et al., Genetic recombination of human immunodeficiency virus, J Virol, vol.63, issue.3, pp.1455-1459, 1989.

G. Fang, B. Weiser, C. Kuiken, S. M. Philpott, R. et al., Recombination following superinfection by HIV-1, AIDS, vol.18, issue.2, pp.153-159, 2004.

E. Simon-lorière, R. Galetto, and M. Negroni, Caractéristiques mécanistiques de la recombinaison chez le virus de l'immunodéficience humaine, Virologie, vol.10, pp.431-442, 2006.

R. P. Junghans, L. R. Boone, and A. M. Skalka, Retroviral DNA H structures: displacement-assimilation model of recombination, Cell, vol.30, issue.1, pp.53-62, 1982.

A. E. Jetzt, H. Yu, G. J. Klarmann, R. Y. Preston, B. D. Dougherty et al., High rate of recombination throughout the human immunodeficiency virus type 1 genome, J Virol, vol.74, issue.3, pp.1234-1240, 2000.

M. M. Lai, RNA recombination in animal and plant viruses, Microbiol Rev, vol.56, issue.1, pp.61-79, 1992.

E. Simon-loriere and E. C. Holmes, Why do RNA viruses recombine?, Nat Rev Microbiol, vol.9, issue.8, pp.617-626, 2011.

A. Telesnitsky and S. P. Goff, Two defective forms of reverse transcriptase can complement to restore retroviral infectivity, EMBO J, vol.12, issue.11, pp.4433-4438, 1993.

F. Oyama, R. Kikuchi, R. J. Crouch, and T. Uchida, Intrinsic properties of reverse transcriptase in reverse transcription, J Biol Chem, vol.264, issue.31, pp.18808-18817, 1989.

M. S. Krug and S. L. Berger, Ribonuclease H activities associated with viral reverse transcriptases are endonucleases, Proc Natl Acad Sci U S A, vol.86, issue.10, pp.3539-3543, 1989.

M. Wisniewski, M. Balakrishnan, C. Palaniappan, P. J. Fay, and R. A. Bambara, The sequential mechanism of HIV reverse transcriptase RNase H, J Biol Chem, vol.275, issue.48, pp.37664-37671, 2000.

S. J. Schultz, M. Zhang, and J. J. Champoux, Recognition of internal cleavage sites by retroviral RNases H, J Mol Biol, vol.344, issue.3, pp.635-652, 2004.

J. M. Coffin, Structure, replication, and recombination of retrovirus genomes: some unifying hypotheses, J Gen Virol, vol.42, issue.1, pp.1-26, 1979.

J. J. Destefano, L. M. Mallaber, L. Rodriguez-rodriguez, P. J. Fay, and R. A. Bambara, Requirements for strand transfer between internal regions of heteropolymer templates by human immunodeficiency virus reverse transcriptase, J Virol, vol.66, issue.11, pp.6370-6378, 1992.

J. J. Destefano, R. A. Bambara, and P. J. Fay, The mechanism of human immunodeficiency virus reverse transcriptase-catalyzed strand transfer from internal regions of heteropolymeric RNA templates, J Biol Chem, vol.269, issue.1, pp.161-168, 1994.

J. K. Kim, C. Palaniappan, W. Wu, P. J. Fay, and R. A. Bambara, Evidence for a unique mechanism of strand transfer from the transactivation response region of HIV-1, J Biol Chem, vol.272, issue.27, pp.16769-16777, 1997.

M. Balakrishnan, P. J. Fay, and R. A. Bambara, The kissing hairpin sequence promotes recombination within the HIV-I 5' leader region, J Biol Chem, vol.276, issue.39, pp.36482-36492, 2001.

A. Moumen, L. Polomack, B. Roques, H. Buc, and M. Negroni, The HIV-1 repeated sequence R as a robust hotspot for copy-choice recombination, Nucleic Acids Res, vol.29, issue.18, pp.3814-3821, 2001.

R. Galetto, A. Moumen, V. Giacomoni, M. Veron, P. Charneau et al., The structure of HIV-1 genomic RNA in the gp120 gene determines a recombination hot spot in vivo, J Biol Chem, vol.279, issue.35, pp.36625-36632, 2004.

R. Galetto and M. Negroni, Mechanistic features of recombination in HIV, AIDS Rev, vol.7, issue.2, pp.92-102, 2005.

E. Simon-loriere, R. Galetto, M. Hamoudi, J. Archer, P. Lefeuvre et al., Molecular mechanisms of recombination restriction in the envelope gene of the human immunodeficiency virus, PLoS Pathog, vol.5, issue.5, p.1000418, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00484470

E. Simon-loriere, D. P. Martin, K. M. Weeks, and M. Negroni, RNA structures facilitate recombination-mediated gene swapping in HIV-1, J Virol, vol.84, issue.24, pp.12675-12682, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00530063

M. Hamoudi, H. Medjahed, J. Sodrosky, A. Finzi, and M. Negroni,

H. A. Baird, Y. Gao, R. Galetto, M. Lalonde, R. M. Anthony et al., Influence of sequence identity and unique breakpoints on the frequency of intersubtype HIV-1 recombination, Retrovirology, vol.3, p.91, 2006.

H. A. Baird, R. Galetto, Y. Gao, E. Simon-loriere, M. Abreha et al., Sequence determinants of breakpoint location during HIV-1 intersubtype recombination, Nucleic Acids Res, vol.34, issue.18, pp.5203-5216, 2006.

J. Fan, M. Negroni, and D. L. Robertson, The distribution of HIV-1 recombination breakpoints, Infect Genet Evol, vol.7, issue.6, pp.717-723, 2007.

J. Archer, J. W. Pinney, J. Fan, E. Simon-loriere, E. J. Arts et al., Identifying the important HIV-1 recombination breakpoints, PLoS Comput Biol, vol.4, issue.9, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00356326

L. Jia, L. Li, T. Gui, S. Liu, H. Li et al., Analysis of HIV-1 intersubtype recombination breakpoints suggests region with high pairing probability may be a more fundamental factor than sequence similarity affecting HIV-1 recombination, Virol J, vol.13, issue.1, p.156, 2016.

M. Choisy, C. H. Woelk, J. F. Guegan, and D. L. Robertson, Comparative study of adaptive molecular evolution in different human immunodeficiency virus groups and subtypes, J Virol, vol.78, issue.4, pp.1962-1970, 2004.

W. Yang, J. P. Bielawski, and Z. Yang, Widespread adaptive evolution in the human immunodeficiency virus type 1 genome, J Mol Evol, vol.57, issue.2, pp.212-221, 2003.

Y. Liu, J. Mcnevin, J. Cao, H. Zhao, I. Genowati et al., Selection on the human immunodeficiency virus type 1 proteome following primary infection, J Virol, vol.80, pp.9519-9529, 2006.

D. P. Martin, E. Van-der-walt, D. Posada, and E. P. Rybicki, The evolutionary value of recombination is constrained by genome modularity, PLoS Genet, vol.1, issue.4, p.51, 2005.

D. A. Drummond, J. J. Silberg, M. M. Meyer, C. O. Wilke, and F. H. Arnold, On the conservative nature of intragenic recombination, Proc Natl Acad Sci U S A, vol.102, issue.15, pp.5380-5385, 2005.

C. A. Voigt, C. Martinez, Z. G. Wang, S. L. Mayo, and F. H. Arnold, Protein building blocks preserved by recombination, Nat Struct Biol, vol.9, issue.7, pp.553-558, 2002.

A. Crameri, S. A. Raillard, E. Bermudez, and W. P. Stemmer, DNA shuffling of a family of genes from diverse species accelerates directed evolution, Nature, vol.391, issue.6664, pp.288-291, 1998.

W. P. Stemmer, Rapid evolution of a protein in vitro by DNA shuffling, Nature, vol.370, issue.6488, pp.389-391, 1994.

M. M. Meyer, J. J. Silberg, C. A. Voigt, J. B. Endelman, S. L. Mayo et al., Library analysis of SCHEMAguided protein recombination, Protein Sci, vol.12, issue.8, pp.1686-1693, 2003.

M. Ostermeier and S. J. Benkovic, Evolution of protein function by domain swapping, Adv Protein Chem, vol.55, pp.29-77, 2000.

H. Song, E. E. Giorgi, V. V. Ganusov, F. Cai, G. Athreya et al., Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infection, Nat Commun, vol.9, issue.1, p.1928, 2018.

T. Lenormand and S. P. Otto, The evolution of recombination in a heterogeneous environment, Genetics, vol.156, issue.1, pp.423-438, 2000.

S. P. Otto and T. Lenormand, Resolving the paradox of sex and recombination, Nat Rev Genet, vol.3, issue.4, pp.252-261, 2002.

N. H. Barton, Mutation and the evolution of recombination, Philos Trans R Soc Lond B Biol Sci, vol.365, pp.1281-1294, 1544.

W. R. Rice, Experimental tests of the adaptive significance of sexual recombination, Nat Rev Genet, vol.3, issue.4, pp.241-251, 2002.

Y. Iwabu, H. Mizuta, M. Kawase, M. Kameoka, T. Goto et al., Superinfection of defective human immunodeficiency virus type 1 with different subtypes of wild-type virus efficiently produces infectious variants with the initial viral phenotypes by complementation followed by recombination, Microbes Infect, vol.10, issue.5, pp.504-513, 2008.

Y. Quan, H. Xu, and M. A. Wainberg, Defective HIV-1 quasispecies in the form of multiply drug-resistant proviral DNA within cells can be rescued by superinfection with different subtype variants of HIV-1 and by HIV-2 and SIV, J Antimicrob Chemother, vol.69, issue.1, pp.21-27, 2014.

R. J. Brown, P. J. Peters, C. Caron, M. P. Gonzalez-perez, L. Stones et al., Intercompartmental recombination of HIV-1 contributes to env intrahost diversity and modulates viral tropism and sensitivity to entry inhibitors, J Virol, vol.85, issue.12, pp.6024-6037, 2011.

A. J. Ritchie, F. Cai, N. M. Smith, S. Chen, H. Song et al., Recombination-mediated escape from primary CD8+ T cells in acute HIV-1 infection, Retrovirology, vol.11, p.69, 2014.

H. Streeck, B. Li, A. F. Poon, A. Schneidewind, A. D. Gladden et al., Immune-driven recombination and loss of control after HIV superinfection, J Exp Med, vol.205, issue.8, pp.1789-1796, 2008.

T. Nora, C. Charpentier, O. Tenaillon, C. Hoede, F. Clavel et al., Contribution of recombination to the evolution of human immunodeficiency viruses expressing resistance to antiretroviral treatment, J Virol, vol.81, issue.14, pp.7620-7628, 2007.

L. Moutouh, J. Corbeil, and D. D. Richman, Recombination leads to the rapid emergence of HIV-1 dually resistant mutants under selective drug pressure, Proc Natl Acad Sci, vol.93, issue.12, pp.6106-6111, 1996.

Y. Nishimura, M. Shingai, W. R. Lee, R. Sadjadpour, O. K. Donau et al., Recombination-mediated changes in coreceptor usage confer an augmented pathogenic phenotype in a nonhuman primate model of HIV-1-induced AIDS, J Virol, vol.85, issue.20, pp.10617-10626, 2011.

S. L. Liu, J. E. Mittler, D. C. Nickle, T. M. Mulvania, D. Shriner et al., Selection for human immunodeficiency virus type 1 recombinants in a patient with rapid progression to AIDS, J Virol, vol.76, issue.21, pp.10674-10684, 2002.

D. L. Robertson, . Aj, and J. A. Bradac, Theoretical Biology and Biophysics Group, 1999.

D. L. Robertson, J. P. Anderson, J. A. Bradac, J. K. Carr, B. Foley et al., HIV-1 nomenclature proposal, Science, vol.288, issue.5463, pp.55-56, 2000.

M. M. Thomson, L. Perez-alvarez, and R. Najera, Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy, Lancet Infect Dis, vol.2, issue.8, pp.461-471, 2002.

A. B. Abecasis, P. Lemey, N. Vidal, T. De-oliveira, M. Peeters et al., Recombination confounds the early evolutionary history of human immunodeficiency virus type 1: subtype G is a circulating recombinant form, J Virol, vol.81, issue.16, pp.8543-8551, 2007.

K. Ozato, D. M. Shin, T. H. Chang, and H. C. Morse, TRIM family proteins and their emerging roles in innate immunity, Nat Rev Immunol, vol.8, issue.11, pp.849-860, 2008.

T. M. Howard and S. Rasheed, Genomic structure and nucleotide sequence analysis of a new HIV type 1 subtype A strain from Nigeria, AIDS Res Hum Retroviruses, vol.12, issue.15, pp.1413-1425, 1996.

J. K. Carr, M. O. Salminen, A. J. Sanders-buell, E. Gotte, D. Birx et al., Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants, Virology, vol.247, issue.1, pp.22-31, 1998.

C. N. Lee, M. Y. Chen, H. S. Lin, M. C. Lee, C. C. Luo et al., HIV type 1 env subtype A variants in Taiwan, AIDS Res Hum Retroviruses, vol.14, issue.9, pp.807-809, 1998.

K. Liitsola, I. Tashkinova, T. Laukkanen, G. Korovina, T. Smolskaja et al., HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad, AIDS, vol.12, issue.14, pp.1907-1919, 1998.

V. V. Lukashov, R. Huismans, A. G. Rakhmanova, Z. N. Lisitsina, N. A. Akhtyrskaya et al., Circulation of subtype A and gagA/envB recombinant HIV type 1 strains among injecting drug users in St. Petersburg, Russia, correlates with geographical origin of infections, AIDS Res Hum Retroviruses, vol.15, issue.17, pp.1577-1583, 1999.

K. Liitsola, K. Holm, A. Bobkov, V. Pokrovsky, T. Smolskaya et al., An AB recombinant and its parental HIV type 1 strains in the area of the former Soviet Union: low requirements for sequence identity in recombination. UNAIDS Virus Isolation Network, AIDS Res Hum Retroviruses, vol.16, issue.11, pp.1047-1053, 2000.

M. Zarandia, T. Tsertsvadze, J. K. Carr, Y. Nadai, J. L. Sanchez et al., HIV-1 genetic diversity and genotypic drug susceptibility in the Republic of Georgia, AIDS Res Hum Retroviruses, vol.22, issue.5, pp.470-476, 2006.

M. Leoz, F. Feyertag, C. Charpentier, C. Delaugerre, M. Wirden et al., Characterization of CRF56_cpx, a new circulating B/CRF02/G recombinant form identified in MSM in France, AIDS, vol.27, issue.14, pp.2309-2312, 2013.

A. Vessiere, D. Rousset, A. Kfutwah, M. Leoz, A. Depatureaux et al., Diagnosis and monitoring of HIV-1 group O-infected patients in Cameroun, J Acquir Immune Defic Syndr, vol.53, issue.1, pp.107-110, 2010.

D. Oliveira, F. Mourez, T. Vessiere, A. Ngoupo, P. A. Alessandri-gradt et al., Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon, Retrovirology, vol.14, issue.1, p.1, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02394198

C. J. Villabona-arenas, J. Domyeum, F. Mouacha, C. Butel, E. Delaporte et al., HIV-1 group O infection in Cameroon from 2006 to 2013: Prevalence, genetic diversity, evolution and public health challenges, Infect Genet Evol, vol.36, pp.210-216, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01949937

A. Ayouba, P. Mauclere, P. M. Martin, P. Cunin, J. Mfoupouendoun et al., HIV-1 group O infection in Cameroon, Emerg Infect Dis, vol.7, issue.3, pp.466-467, 1986.

L. Vergne, A. Bourgeois, E. Mpoudi-ngole, R. Mougnutou, J. Mbuagbaw et al., Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02_AG variant and disease stage, Virology, vol.310, issue.2, pp.254-266, 2003.

C. M. Kabeya, E. Esu-williams, E. Eni, M. Peeters, E. Saman et al., Evidence for HIV-1 group O infection in Nigeria, Lancet, vol.346, issue.8970, p.308, 1995.

E. M. Songok, D. K. Libondo, M. C. Rotich, S. A. Oogo, and P. M. Tukei, Surveillance for HIV-1 subtypes O and M in Kenya, Lancet, vol.347, issue.9016, p.1700, 1996.

L. Heyndrickx, M. Alary, W. Janssens, N. Davo, and G. Van-der-groen, HIV-1 group O and group M dual infection in Benin, Lancet, vol.347, issue.9005, pp.902-903, 1996.

M. Peeters, A. Gaye, S. Mboup, W. Badombena, K. Bassabi et al., Presence of HIV-1 group O infection in West Africa, AIDS, vol.10, issue.3, pp.343-344, 1996.

M. Peeters, A. Gueye, S. Mboup, F. Bibollet-ruche, E. Ekaza et al., Geographical distribution of HIV-1 group O viruses in Africa, AIDS, vol.11, issue.4, pp.493-498, 1997.

J. Nkengasong, F. Sylla-koko, M. Peeters, D. Ellenberger, M. Sassan-morokro et al., HIV-1 group O virus infection in Abidjan, AIDS, vol.12, issue.12, pp.1565-1566, 1998.

H. Hampl, D. Sawitzky, M. Stoffler-meilicke, A. Groh, M. Schmitt et al., First case of HIV-1 subtype 0 infection in Germany, Infection, vol.23, issue.6, pp.369-370, 1995.

M. A. Rayfield, P. Sullivan, C. I. Bandea, L. Britvan, R. A. Otten et al., HIV-1 group O virus identified for the first time in the United States, Emerg Infect Dis, vol.2, issue.3, pp.209-212, 1996.

V. Soriano, M. Gutierrez, G. Garcia-lerma, O. Aguilera, A. Mas et al., First case of HIV-1 group O infection in Spain, Vox Sang, vol.71, issue.1, p.66, 1996.

K. Gould, Infection with HIV-1 group O, AIDS Patient Care STDS, vol.11, issue.6, pp.399-405, 1997.

P. S. Sullivan, A. N. Do, D. Ellenberger, C. P. Pau, S. Paul et al., Human immunodeficiency virus (HIV) subtype surveillance of African-born persons at risk for group O and group N HIV infections in the United States, J Infect Dis, vol.181, issue.2, pp.463-469, 2000.

H. Agut, D. Candotti, B. Rabanel, J. M. Huraux, G. Remy et al., Isolation of atypical HIV-1-related retrovirus from AIDS patient, Lancet, vol.340, issue.8820, pp.681-682, 1992.

A. Depatureaux, M. Leoz, D. Oliveira, F. Gueudin, M. Damond et al., Specific diagnosis and follow-up of HIV-1 group O infection: RES-O data

, Med Mal Infect, vol.40, issue.12, pp.669-676, 2010.

S. F. Kluge, K. Mack, S. S. Iyer, F. M. Pujol, A. Heigele et al., Nef proteins of epidemic HIV-1 group O strains antagonize human tetherin, Cell Host Microbe, vol.16, issue.5, pp.639-650, 2014.

D. Sauter and F. Kirchhoff, Key Viral Adaptations Preceding the AIDS Pandemic, Cell Host Microbe, vol.25, issue.1, pp.27-38, 2019.

K. K. Arien, A. Abraha, M. E. Quinones-mateu, L. Kestens, G. Vanham et al., The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates, J Virol, vol.79, issue.14, pp.8979-8990, 2005.

C. Kouanfack, G. Unal, L. Schaeffer, A. Kfutwah, A. Aghokeng et al., Comparative immunovirological and clinical responses to antiretroviral therapy between HIV-1 group O-and HIV-1 group Minfected patients (ANRS 12168 DynaMO study), Clin Infect Dis, 2019.

G. Unal, Infection par le VIH-1 groupe O : Etude des caractéristiques épidémiologiques et de la réponse immuno-virologique aux antirétroviraux, 2018.

M. Leoz, HIV-1 Group O Genetic Diversity: Characterization, Evolution and Associated Viral Properties: Rouen Normandie, 2016.

P. Roques, D. L. Robertson, S. Souquiere, F. Damond, A. Ayouba et al., Phylogenetic analysis of 49 newly derived HIV-1 group O strains: high viral diversity but no group M-like subtype structure, Virology, vol.302, issue.2, pp.259-273, 2002.

M. E. Quinones-mateu, J. L. Albright, A. Mas, V. Soriano, and E. J. Arts, Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1, J Virol, vol.72, issue.11, pp.9002-9015, 1998.

M. Leoz, A. Depatureaux, A. Vessiere, B. Roquebert, F. Damond et al., Integrase polymorphism and HIV-1 group O diversity, AIDS, vol.22, issue.10, pp.1239-1243, 2008.

A. Ayouba, S. Souquieres, B. Njinku, P. M. Martin, M. C. Muller-trutwin et al., HIV-1 group N among HIV-1-seropositive individuals in Cameroon, AIDS, vol.14, issue.16, pp.2623-2625, 2000.

P. Bodelle, A. Vallari, R. Coffey, C. P. Mcarthur, M. Beyeme et al., Identification and genomic sequence of an HIV type 1 group N isolate from Cameroon, AIDS Res Hum Retroviruses, vol.20, issue.8, pp.902-908, 2004.

C. Delaugerre, D. Oliveira, F. Lascoux-combe, C. Plantier, J. C. Simon et al., HIV-1 group N: travelling beyond Cameroon, Lancet, vol.378, issue.9806, p.1894, 2011.

M. A. Rodgers, A. S. Vallari, B. Harris, J. Yamaguchi, V. Holzmayer et al.,

N. Group and H. Ae, HTLV-3 strains in rural South Cameroon, Virology, vol.504, pp.141-151, 2017.

M. A. Rodgers, A. S. Vallari, J. Yamaguchi, V. Holzmayer, B. Harris et al., ARCHITECT HIV Combo Ag/Ab and RealTime HIV-1 Assays Detect Diverse HIV Strains in Clinical Specimens, AIDS Res Hum Retroviruses, vol.34, issue.3, pp.314-318, 2018.

P. Roques, D. L. Robertson, S. Souquiere, C. Apetrei, E. Nerrienet et al., Phylogenetic characteristics of three new HIV-1 N strains and implications for the origin of group N, AIDS, vol.18, issue.10, pp.1371-1381, 2004.

A. Vallari, P. Bodelle, C. Ngansop, F. Makamche, N. Ndembi et al., Four new HIV-1 group N isolates from Cameroon: Prevalence continues to be low, AIDS Res Hum Retroviruses, vol.26, issue.1, pp.109-115, 2010.

J. Yamaguchi, R. Coffey, A. Vallari, C. Ngansop, D. Mbanya et al., Identification of HIV type 1 group N infections in a husband and wife in Cameroon: viral genome sequences provide evidence for horizontal transmission, AIDS Res Hum Retroviruses, vol.22, issue.1, pp.83-92, 2006.

J. Yamaguchi, C. P. Mcarthur, A. Vallari, R. Coffey, P. Bodelle et al., HIV-1 Group N: evidence of ongoing transmission in Cameroon, AIDS Res Hum Retroviruses, vol.22, issue.5, pp.453-457, 2006.

P. A. Ngoupo, Fréquence et profil génétique des doubles infections VIH-1/M+O et formes recombinantes VIH-1/MO au Cameroun: Rouen Normandie, 2016.

F. Damond, M. Worobey, P. Campa, I. Farfara, C. G. Matheron et al., Identification of a highly divergent HIV type 2 and proposal for a change in HIV type 2 classification, AIDS Res Hum Retroviruses, vol.20, issue.6, pp.666-672, 2004.

F. Gao, L. Yue, D. L. Robertson, S. C. Hill, H. Hui et al., Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology, J Virol, vol.68, issue.11, pp.7433-7447, 1994.

S. Ibe, Y. Yokomaku, T. Shiino, R. Tanaka, J. Hattori et al., HIV-2 CRF01_AB: first circulating recombinant form of HIV-2, J Acquir Immune Defic Syndr, vol.54, issue.3, pp.241-247, 2010.

J. Yamaguchi, A. Vallari, N. Ndembi, R. Coffey, C. Ngansop et al., HIV type 2 intergroup recombinant identified in Cameroon, AIDS Res Hum Retroviruses, vol.24, issue.1, pp.86-91, 2008.

J. Hemelaar, E. Gouws, P. D. Ghys, and S. Osmanov, Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004, AIDS, vol.20, issue.16, pp.13-23, 2006.

K. Motomura, J. Chen, and W. S. Hu, Genetic recombination between human immunodeficiency virus type 1 (HIV-1) and HIV-2, two distinct human lentiviruses, J Virol, vol.82, issue.4, pp.1923-1933, 2008.

M. Peeters, F. Liegeois, N. Torimiro, A. Bourgeois, E. Mpoudi et al., Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient, J Virol, vol.73, issue.9, pp.7368-7375, 1999.

J. Yamaguchi, P. Bodelle, A. S. Vallari, R. Coffey, C. P. Mcarthur et al., HIV infections in northwestern Cameroon: identification of HIV type 1 group O and dual HIV type 1 group M and group O infections, AIDS Res Hum Retroviruses, vol.20, issue.9, pp.944-957, 2004.

J. Takehisa, L. Zekeng, E. Ido, Y. Yamaguchi-kabata, I. Mboudjeka et al., Human immunodeficiency virus type 1 intergroup (M/O) recombination in cameroon, J Virol, vol.73, issue.8, pp.6810-6820, 1999.

J. Takehisa, L. Zekeng, E. Ido, I. Mboudjeka, H. Moriyama et al., Various types of HIV mixed infections in Cameroon, Virology, vol.245, issue.1, pp.1-10, 1998.

D. Brand, A. Beby-defaux, M. Mace, S. Brunet, A. Moreau et al., First identification of HIV-1 groups M and O dual infections in Europe, AIDS, vol.18, issue.18, pp.2425-2428, 2004.

J. C. Plantier, V. Lemee, I. Dorval, M. Gueudin, J. Braun et al., HIV-1 group M superinfection in an HIV-1 group O-infected patient, AIDS, vol.18, issue.18, pp.2444-2446, 2004.

D. Oliveira, F. Cappy, P. Lemee, V. Moisan, A. Pronier et al., Detection of numerous HIV-1/MO recombinants in France, AIDS, vol.32, issue.10, pp.1289-1299, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02344126

P. A. Ngoupo, S. A. Sadeuh-mba, D. Oliveira, F. Ngono, V. Ngono et al., First evidence of transmission of an HIV-1 M/O intergroup recombinant virus, AIDS, vol.30, issue.1, pp.1-8, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02442685

A. Vessiere, M. Leoz, V. Brodard, C. Strady, V. Lemee et al., First evidence of a HIV-1 M/O recombinant form circulating outside Cameroon, AIDS, vol.24, issue.7, pp.1079-1082, 2010.
URL : https://hal.archives-ouvertes.fr/hal-02264822

A. Moisan, Formes recombinantes VIH-1 inter-groupes M et O : profils moléculaires et rôle potentiel des facteurs de restriction cellulaires et des réseaux de co-évolution protéique: Rouen Normandie, 2016.

C. A. Brennan, P. Bodelle, R. Coffey, S. G. Devare, A. Golden et al., The prevalence of diverse HIV-1 strains was stable in Cameroonian blood donors from 1996 to, J Acquir Immune Defic Syndr, vol.49, issue.4, pp.432-439, 2004.

M. Tongo, D. P. Martin, L. Zembe, E. Mpoudi-ngole, C. Williamson et al., Characterization of HIV-1 gag and nef in Cameroon: further evidence of extreme diversity at the origin of the HIV-1 group M epidemic, Virol J, vol.10, p.29, 2013.

G. Magiorkinis, D. Paraskevis, A. M. Vandamme, E. Magiorkinis, V. Sypsa et al., In vivo characteristics of human immunodeficiency virus type 1 intersubtype recombination: determination of hot spots and correlation with sequence similarity, J Gen Virol, vol.84, pp.2715-2722, 2003.

G. Unal, E. Alessandri-gradt, M. Leoz, J. Pavie, C. Lefevre et al., Human Immunodeficiency Virus Type 1 Group O Infection in France: Clinical Features and Immunovirological Response to Antiretrovirals, Clin Infect Dis, vol.66, issue.11, pp.1785-1793, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-02129078

A. Vallejo, A. Heredia, A. Mas, S. F. Lee, J. S. Epstein et al., Tropism, coreceptor use, and phylogenetic analysis of both the V3 loop and the protease gene of three novel HIV-1 group O isolates, J Acquir Immune Defic Syndr Hum Retrovirol, vol.18, issue.5, pp.417-425, 1998.

A. Depatureaux, C. Charpentier, M. Leoz, G. Unal, F. Damond et al., Impact of HIV-1 group O genetic diversity on genotypic resistance interpretation by algorithms designed for HIV-1 group M, J Acquir Immune Defic Syndr, vol.56, issue.2, pp.139-145, 2011.

E. Alessandri-gradt, C. G. Tourneroche, A. Bertine, M. Leoz, M. Charpentier et al., HIV-1 non-group M phenotypic susceptibility to integrase strand transfer inhibitors, J Antimicrob Chemother, vol.72, issue.9, pp.2431-2437, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02394132

A. Depatureaux, T. Mesplede, P. Quashie, M. Oliveira, D. Moisi et al., HIV-1 Group O Resistance Against Integrase Inhibitors, J Acquir Immune Defic Syndr, vol.70, issue.1, pp.9-15, 2015.

, WHO. WHO recommends dolutegravir as preferred HIV treatment option in all populations, 2019.

S. Geuenich, L. Kaderali, I. Allespach, S. Sertel, and O. T. Keppler, Biological signature characteristics of primary isolates from human immunodeficiency virus type 1 group O in ex vivo human tonsil histocultures, J Virol, vol.83, issue.20, pp.10494-10503, 2009.

D. Sauter, D. Hotter, B. Van-driessche, C. M. Sturzel, S. F. Kluge et al., Differential regulation of NF-kappaB-mediated proviral and antiviral host gene expression by primate lentiviral Nef and Vpu proteins, Cell Rep, vol.10, issue.4, pp.586-599, 2015.

K. Mack, K. Starz, D. Sauter, S. Langer, F. Bibollet-ruche et al., Efficient Vpu-Mediated Tetherin Antagonism by an HIV-1 Group O Strain, J Virol, vol.91, issue.6, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02394301

R. Collman, J. W. Balliet, S. A. Gregory, H. Friedman, D. L. Kolson et al., An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1, J Virol, vol.66, issue.12, pp.7517-7521, 1992.

P. Novelli, C. Vella, J. Oxford, and R. S. Daniels, Construction and characterization of a full-length HIV-1(92UG001) subtype D infectious molecular clone, AIDS Res Hum Retroviruses, vol.18, issue.1, pp.85-88, 2002.

D. G. Gibson, L. Young, R. Y. Chuang, J. C. Venter, C. A. Hutchison et al., Enzymatic assembly of DNA molecules up to several hundred kilobases, Nat Methods, vol.6, issue.5, pp.343-345, 2009.

D. G. Gibson, H. O. Smith, C. A. Hutchison, J. C. Venter, and C. Merryman, Chemical synthesis of the mouse mitochondrial genome, Nat Methods, vol.7, issue.11, pp.901-903, 2010.

F. Tangy, P. Charneau, and Y. Jacob, Cells and methodology to generate non-segmented negative strand RNA viruses, 2006.

R. D. Salter, D. N. Howell, and P. Cresswell, Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids, Immunogenetics, vol.21, issue.3, pp.235-246, 1985.

J. Zhou and C. Aiken, Nef enhances human immunodeficiency virus type 1 infectivity resulting from intervirion fusion: evidence supporting a role for Nef at the virion envelope, J Virol, vol.75, issue.13, pp.5851-5859, 2001.

L. Selig, J. C. Pages, V. Tanchou, S. Preveral, C. Berlioz-torrent et al., Interaction with the p6 domain of the gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate lentiviruses, J Virol, vol.73, issue.1, pp.592-600, 1999.

E. Beaumont, D. Vendrame, B. Verrier, E. Roch, F. Biron et al., Matrix and envelope coevolution revealed in a patient monitored since primary infection with human immunodeficiency virus type 1, J Virol, vol.83, issue.19, pp.9875-9889, 2009.

A. Chakraborty, G. Q. Sun, L. Mustavich, S. H. Huang, and B. L. Li, Biochemical interactions between HIV-1 integrase and reverse transcriptase, FEBS Lett, vol.587, issue.5, pp.425-429, 2013.

M. H. Arachchilage and H. Piontkivska, Coevolutionary Analysis Identifies Protein-Protein Interaction Sites between HIV-1 Reverse Transcriptase and Integrase, Virus Evol, vol.2, issue.1, 2016.

D. M. Tebit, L. Zekeng, L. Kaptue, L. Gurtler, O. T. Fackler et al., Construction and characterization of an HIV-1 group O infectious molecular clone and analysis of vpr-and nef-negative derivatives, Virology, vol.326, issue.2, pp.329-339, 2004.

T. D. Ly, J. C. Plantier, L. Leballais, S. Gonzalo, V. Lemee et al., The variable sensitivity of HIV Ag/Ab combination assays in the detection of p24Ag according to genotype could compromise the diagnosis of early HIV infection, J Clin Virol, vol.55, issue.2, pp.121-127, 2012.

J. Braun, J. C. Plantier, M. F. Hellot, E. Tuaillon, M. Gueudin et al., A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes, Aids, vol.17, issue.3, pp.331-336, 2003.

H. Mohri, N. Prada, and M. Markowitz, Viral envelope is a major determinant of enhanced fitness of a multidrug-resistant HIV-1 variant, J Acquir Immune Defic Syndr, vol.68, issue.5, pp.487-494, 2015.

A. J. Marozsan, D. M. Moore, M. A. Lobritz, E. Fraundorf, A. Abraha et al., Differences in the fitness of two diverse wild-type human immunodeficiency virus type 1 isolates are related to the efficiency of cell binding and entry, J Virol, vol.79, issue.11, pp.7121-7134, 2005.

S. Palmer, M. Kearney, F. Maldarelli, E. K. Halvas, C. J. Bixby et al., Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis, J Clin Microbiol, vol.43, issue.1, pp.406-413, 2005.

B. F. Keele, E. E. Giorgi, J. F. Salazar-gonzalez, J. M. Decker, K. T. Pham et al., Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection, Proc Natl Acad Sci, vol.105, issue.21, pp.7552-7557, 2008.

T. Mourez, F. Simon, and J. C. Plantier, Non-M variants of human immunodeficiency virus type 1, Clin Microbiol Rev, vol.26, issue.3, pp.448-461, 2013.

T. Mourez, V. Lemee, V. Delbos, C. Delaugerre, E. Alessandri-gradt et al., HIV rapid screening tests and self-tests: Be aware of differences in performance and cautious of vendors, EBioMedicine, vol.37, pp.382-391, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02372796

V. Lemee, M. Leoz, E. M. , D. Oliveira, F. Plantier et al., Performance of the Liaison XL Murex HIV Ab/Ag test on clinical samples representing current epidemic HIV variants, J Clin Microbiol, vol.52, issue.9, pp.3277-3279, 2014.

, ANRS resistance algorithm

F. Simon, S. Souquiere, F. Damond, A. Kfutwah, M. Makuwa et al., Synthetic peptide strategy for the detection of and discrimination among highly divergent primate lentiviruses, AIDS Res Hum Retroviruses, vol.17, issue.10, pp.937-952, 2001.

F. Barin, J. C. Plantier, D. Brand, S. Brunet, A. Moreau et al., Human immunodeficiency virus serotyping on dried serum spots as a screening tool for the surveillance of the AIDS epidemic, J Med Virol, vol.78, issue.1, pp.13-18, 2006.

J. C. Plantier, R. Dachraoui, V. Lemee, M. Gueudin, F. Borsa-lebas et al., HIV-1 resistance genotyping on dried serum spots, Aids, vol.19, issue.4, pp.391-397, 2005.

R. Dachraoui, A. Depatureaux, M. Chakroun, I. Fodha, A. Letaief et al., Monitoring of HIV-1 resistance in Tunisia (North Africa) with a dried plasma spot strategy, J Acquir Immune Defic Syndr, vol.47, issue.4, pp.522-525, 2008.

L. Heyndrickx, W. Janssens, L. Gurtler, L. Zekeng, I. Loussert-ajaka et al., Differential diagnosis of HIV type 1 group O and M infection by polymerase chain reaction and PstI restriction analysis of the pol gene fragment, AIDS Res Hum Retroviruses, vol.14, issue.11, pp.973-977, 1998.

K. S. Lole, R. C. Bollinger, R. S. Paranjape, D. Gadkari, S. S. Kulkarni et al., Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination, J Virol, vol.73, issue.1, pp.152-160, 1999.

N. Saitou and M. Nei, The neighbor-joining method: a new method for reconstructing phylogenetic trees, Mol Biol Evol, vol.4, issue.4, pp.406-425, 1987.

M. Kimura, A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences, J Mol Evol, vol.16, issue.2, pp.111-120, 1980.

M. Gueudin, M. Leoz, V. Lemee, D. Oliveira, F. Vessiere et al., A new real-time quantitative PCR for diagnosis and monitoring of HIV-1 group O infection, J Clin Microbiol, vol.50, issue.3, pp.831-836, 2012.

P. Cappy, Profil de recombinaison, genèse et étude fonctionnelle des recombinants VIH-MO : à la frontière de nouvelles espèces de VIH, 2013.